These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26976670)

  • 1. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
    Köfalvi A; Lemos C; Martín-Moreno AM; Pinheiro BS; García-García L; Pozo MA; Valério-Fernandes Â; Beleza RO; Agostinho P; Rodrigues RJ; Pasquaré SJ; Cunha RA; de Ceballos ML
    Neuropharmacology; 2016 Nov; 110(Pt A):519-529. PubMed ID: 26976670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system.
    Martín-Sánchez A; Warnault V; Montagud-Romero S; Pastor A; Mondragón N; De La Torre R; Valverde O
    Pharmacol Biochem Behav; 2019 Aug; 183():22-31. PubMed ID: 31220547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent.
    Nicolussi S; Chicca A; Rau M; Rihs S; Soeberdt M; Abels C; Gertsch J
    Biochem Pharmacol; 2014 Dec; 92(4):669-89. PubMed ID: 25283614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-2 cannabinoid receptors in neurodegeneration.
    Bisogno T; Oddi S; Piccoli A; Fazio D; Maccarrone M
    Pharmacol Res; 2016 Sep; 111():721-730. PubMed ID: 27450295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex.
    Sticht MA; Limebeer CL; Rafla BR; Abdullah RA; Poklis JL; Ho W; Niphakis MJ; Cravatt BF; Sharkey KA; Lichtman AH; Parker LA
    Neuropharmacology; 2016 Mar; 102():92-102. PubMed ID: 26541329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons.
    Stumpf A; Parthier D; Sammons RP; Stempel AV; Breustedt J; Rost BR; Schmitz D
    Neuropharmacology; 2018 Sep; 139():217-225. PubMed ID: 30025920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
    Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
    Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.
    Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M
    J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
    Nader J; Rapino C; Gennequin B; Chavant F; Francheteau M; Makriyannis A; Duranti A; Maccarrone M; Solinas M; Thiriet N
    Neuropharmacology; 2014 Dec; 87():214-21. PubMed ID: 24709540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease.
    Berg BB; Linhares AFS; Martins DM; Rachid MA; Cau SBA; Souza GG; Carvalho JCS; Sorgi CA; Romero TRL; Pinho V; Teixeira MM; Castor MGME
    Eur J Pharmacol; 2023 Oct; 956():175932. PubMed ID: 37536622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosting brain glucose metabolism to fight neurodegeneration?
    de Ceballos ML; Köfalvi A
    Oncotarget; 2017 Feb; 8(9):14273-14274. PubMed ID: 28184023
    [No Abstract]   [Full Text] [Related]  

  • 14. Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.
    Zhang J; Chen C
    Mol Neurobiol; 2018 Jun; 55(6):4802-4810. PubMed ID: 28733897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release.
    Bari M; Bonifacino T; Milanese M; Spagnuolo P; Zappettini S; Battista N; Giribaldi F; Usai C; Bonanno G; Maccarrone M
    Cell Mol Life Sci; 2011 Mar; 68(5):833-45. PubMed ID: 20711816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
    Tambaro S; Casu MA; Mastinu A; Lazzari P
    Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells.
    Maccarrone M; Fiori A; Bari M; Granata F; Gasperi V; De Stefano ME; Finazzi-Agrò A; Strom R
    Thromb Haemost; 2006 Jan; 95(1):117-27. PubMed ID: 16543970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.